Denver CO 前列腺癌临床试验
19项针对 前列腺癌的研究正在 Denver及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Rocky Mountain Cancer Center, Denver
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
招募中3 期
- Kaiser Permanente-Franklin, Denver
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- Sarah Cannon Research Institute at HealthOne, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- AdventHealth Porter, Denver
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
招募中1/2 期
- Sarah Cannon Research Institute 1, Denver
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
招募中3 期
- AdventHealth Medical Group Urology of Denver, Denver
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
招募中2/3 期
- Rocky Mountain Cancer Centers, Denver
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
招募中3 期
- Rocky Mountain Cancer Centers, Denver
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
招募中3 期
- Rocky Mountain Cancer Centers, Denver
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
招募中1/2 期
- GSK Investigational Site, Denver
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
招募中1 期
- Rocky Mountain Cancer Centers, Denver
- United States Oncology Regulatory Affairs Corporate Office, Denver
- US Oncology Research Investigational Products Center, Denver
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中欢迎健康志愿者
- Kaiser Permanente-Franklin, Denver
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
招募中1 期
- Sarah Cannon Research Institute - Denver DDU, Denver
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- UCHealth - Cherry Creek, Denver
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients
招募中早期 I 期
- UCHealth-Metro Denver, Denver
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
招募中1/2 期
- Sarah Cannon Research Institute, Denver
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
招募中2 期
- Porter Adventist Hospital, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Denver
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Porter Adventist Hospital, Denver
其他城市的 前列腺癌试验
- New York City, NY103 项研究
- Houston, TX76 项研究
- Los Angeles, CA61 项研究
- Boston, MA59 项研究
- St. Louis, MO46 项研究
- Chicago, IL45 项研究
- San Francisco, CA45 项研究
- Philadelphia, PA44 项研究
- Baltimore, MD43 项研究
- Nashville, TN42 项研究
- Seattle, WA42 项研究
- Washington, DC38 项研究
Denver的其他研究
- 转移性癌症29 项研究
- 乳腺癌28 项研究
- 多发性骨髓瘤27 项研究
- 非小细胞肺癌27 项研究
- 结直肠癌23 项研究
- 黑色素瘤19 项研究
- 癌症（所有类型）18 项研究
- 卵巢癌16 项研究
- 肺癌16 项研究
- 子宫内膜癌15 项研究
- 非霍奇金淋巴瘤14 项研究
- 胰腺癌13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。